Kunming Biomed International Overview

  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Kunming Biomed International General Information

Description

Provider of preclinical research services. The company's preclinical research services specialize in nonhuman primates (NHP) and has AAALAC accredited vivarium, animal research facilities and clinical laboratories, extensive colonies of healthy, SPF and naturalistic disease models of purpose-bred NHPs combined with experienced research and scientific teams, high-end clinical technology platforms and cross-species biomarker programs that can support a wide-range of services while ensuring consistent high-quality results and rapid turnaround time.

Contact Information

Website
www.kbimed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Number 1 Boda road, Yuhua District
  • Chenggong New Town
  • Kunming, Yunnan 650500
  • China
+86 0871 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kunming Biomed International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view Kunming Biomed International’s complete valuation and funding history, request access »

Kunming Biomed International Executive Team (7)

Name Title Board Seat Contact Info
Bob Zang Ph.D Chief Executive Officer
Shaodong Li Chief Operation Officer
Tony Wang Ph.D Chief Technology Officer
Noel Miranda Chief Veterinarian
Lichuan Yang MD Vice President, Model Development and Biomarkers
You’re viewing 5 of 7 executive team members. Get the full list »

Kunming Biomed International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kunming Biomed International Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morningside Group Venture Capital Minority 000 0000 000000 0
To view Kunming Biomed International’s complete investors history, request access »